Wall Street brokerages expect Envision Healthcare Co. (NYSE:EVHC) to report $0.71 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Nine analysts have issued estimates for Envision Healthcare’s earnings. The highest EPS estimate is $0.72 and the lowest is $0.69. Envision Healthcare posted earnings of $0.74 per share during the same quarter last year, which suggests a negative year over year growth rate of 4.1%. The firm is expected to report its next quarterly earnings results after the market closes on Tuesday, May 2nd.

On average, analysts expect that Envision Healthcare will report full-year earnings of $3.93 per share for the current fiscal year, with EPS estimates ranging from $3.86 to $4.07. For the next fiscal year, analysts expect that the company will post earnings of $4.57 per share, with EPS estimates ranging from $4.23 to $4.85. Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side research analysts that cover Envision Healthcare.

Envision Healthcare (NYSE:EVHC) last issued its quarterly earnings results on Tuesday, February 28th. The company reported $1.08 EPS for the quarter, missing the consensus estimate of $1.20 by $0.12. The company earned $1.39 billion during the quarter, compared to analysts’ expectations of $1.41 billion. Envision Healthcare had a return on equity of 8.05% and a net margin of 6.06%. Envision Healthcare’s revenue was up 97.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.07 EPS.

This article was originally published by and is the sole property of American Banking News. If you happen to be reading this article on another website, it was stolen and illegally republished in violation of U.S. and International copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2017/04/20/brokerages-anticipate-envision-healthcare-co-evhc-will-post-earnings-of-0-71-per-share.html

EVHC has been the subject of several recent analyst reports. Zacks Investment Research cut Envision Healthcare from a “buy” rating to a “hold” rating in a report on Monday, February 6th. Barclays PLC restated an “overweight” rating on shares of Envision Healthcare in a report on Tuesday, March 21st. TheStreet lowered Envision Healthcare from a “b-” rating to a “c+” rating in a research note on Thursday, March 9th. Raymond James Financial, Inc. reaffirmed a “strong-buy” rating and issued a $90.00 price objective (down from $100.00) on shares of Envision Healthcare in a research note on Thursday, December 29th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Envision Healthcare in a research note on Thursday, March 16th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $70.44.

TRADEMARK VIOLATION NOTICE: This story was first reported by American Banking News and is the property of of American Banking News. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. & international trademark and copyright laws. The original version of this story can be viewed at https://www.americanbankingnews.com/2017/04/20/brokerages-anticipate-envision-healthcare-co-evhc-will-post-earnings-of-0-71-per-share.html.

Shares of Envision Healthcare (NYSE:EVHC) opened at 57.46 on Thursday. The stock’s 50 day moving average is $62.93 and its 200-day moving average is $52.16. Envision Healthcare has a 12-month low of $57.24 and a 12-month high of $83.27. The stock’s market cap is $6.68 billion.

In other news, insider Robert Jon Coward sold 1,500 shares of the company’s stock in a transaction on Wednesday, March 1st. The stock was sold at an average price of $65.00, for a total transaction of $97,500.00. Following the completion of the sale, the insider now directly owns 104,319 shares of the company’s stock, valued at $6,780,735. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 2.30% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of EVHC. Rhumbline Advisers raised its position in Envision Healthcare by 5.3% in the third quarter. Rhumbline Advisers now owns 179,835 shares of the company’s stock valued at $4,005,000 after buying an additional 9,007 shares during the last quarter. TIAA CREF Investment Management LLC raised its position in Envision Healthcare by 9.6% in the third quarter. TIAA CREF Investment Management LLC now owns 751,276 shares of the company’s stock valued at $16,731,000 after buying an additional 66,057 shares during the last quarter. Teachers Advisors LLC raised its position in Envision Healthcare by 0.8% in the third quarter. Teachers Advisors LLC now owns 692,339 shares of the company’s stock valued at $15,418,000 after buying an additional 5,497 shares during the last quarter. BlackRock Japan Co. Ltd raised its position in Envision Healthcare by 1.2% in the third quarter. BlackRock Japan Co. Ltd now owns 236,193 shares of the company’s stock valued at $5,260,000 after buying an additional 2,814 shares during the last quarter. Finally, IndexIQ Advisors LLC acquired a new position in Envision Healthcare during the third quarter valued at $2,886,000. 35.96% of the stock is currently owned by hedge funds and other institutional investors.

Envision Healthcare Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

5 Day Chart for NYSE:EVHC

Get a free copy of the Zacks research report on Envision Healthcare (EVHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Envision Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Co. and related companies with MarketBeat.com's FREE daily email newsletter.